Crispr Therapeutics shares owned by Henderson Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Henderson Group
from 13F filings
Historical chart of Henderson Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Henderson Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $1.9M | 35k | 53.96 |
| 2024-03-31 | $2.4M | 35k | 68.14 |
| 2023-12-31 | $2.2M | 35k | 62.60 |
| 2023-09-30 | $1.6M | 35k | 45.41 |
| 2023-06-30 | $2.0M | 35k | 56.15 |
| 2023-03-31 | $1.6M | 35k | 45.25 |
| 2022-12-31 | $539k | 13k | 40.67 |
| 2022-09-30 | $867k | 13k | 65.37 |
| 2022-03-31 | $746k | 12k | 62.83 |